Nuvation Bio Inc. (NUVB) Form 8-K — Jun 30, 2026
$NUVBForm 8-KItems 1.01, 1.02, 2.03, 8.01, 9.01Filed Jun 30, 2026, 5:17 PM ET0001193125-26-290823Original filing
Nuvation Bio Inc. completed a registered underwritten public offering of $250.0 million aggregate principal amount of 0.75% Convertible Senior Notes due 2032. The company granted underwriters a 30-day option to purchase up to an additional $37.5 million aggregate principal amount of notes. The notes are unsecured general obligations bearing interest at 0.75% per year, maturing on July 1, 2032.
Key figures
- Debt Amount
- $250.0 million
- Interest Rate
- 0.75%
- Maturity Date
- July 1, 2032
- Gross Proceeds
- $250.0 million
- Net Proceeds
- $241.2 million
- Capped Call Cost
- $14.9 million
- Conversion Price
- $7.84 per share
- Greenshoe Amount
- $37.5 million
- Loan Payoff Amount
- $58.5 million
- Conversion Premium
- 35.0%
- Capped Call Cap Price
- $10.4580 per share
Price after filing
1 day: -4.6%7 days: -0.2%30 days: +16.0%
Close on the filing date to close N calendar days later (from $5.68). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.